OptimizeRx (OPRX) Total Debt (2010 - 2026)

OptimizeRx has disclosed Total Debt across 11 years of filings, most recently posting $20.9 million for Q2 2026.

• In Q2 2026, Total Debt fell 35.75% year-over-year to $20.9 million; the TTM figure through Jun 2026 stood at $20.9 million (down 35.75% YoY), while the FY2025 annual figure was $30.5 million, down 15.83% from the prior year.
• Total Debt came in at $20.9 million for Q2 2026 at OptimizeRx, down from $25.6 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $37.1 million in Q1 2025 to a low of $20.9 million in Q2 2026.
• Average Total Debt over 4 years is $32.6 million, with a median of $35.3 million recorded in 2024.
• Year-over-year, Total Debt increased 3.28% in 2025 and tumbled 35.75% in 2026.
• Over 4 years, Total Debt stood at $36.2 million in 2023, then grew by 0.16% to $36.3 million in 2024, then slipped by 15.83% to $30.5 million in 2025, then plunged by 31.45% to $20.9 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $20.9 million in Q2 2026, $25.6 million in Q1 2026, and $30.5 million in Q4 2025.